Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.080
+0.260 (14.29%)
At close: Apr 14, 2026, 4:00 PM EDT
2.100
+0.020 (0.96%)
Pre-market: Apr 15, 2026, 7:43 AM EDT
ACTU's stock price has decreased by -72.85% in the past year and price targets may not have had time to catch up.

Actuate Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$17.50
Upside
+741.35%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$20$15
Strong BuyMaintains$20$15+621.15%Apr 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+861.54%Nov 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+861.54%Sep 23, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$20
Strong BuyInitiates$20+861.54%Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+861.54%Aug 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$20
Strong BuyInitiates$20+861.54%Mar 17, 2025